Teleflex announced key milestones in the release of two new catheters: the U.S. FDA 510(k) clearance of the Triumph Catheter, and the first clinical use of GuideLiner Coast Catheter.
Published first on TheFly
See Insiders’ Hot Stocks on TipRanks >>
Read More on TFX:
- Teleflex Announces Quarterly Dividend
- Teleflex Reports Fourth Quarter and Full Year 2022 Financial Results
- Teleflex Expands Interventional Cardiology Portfolio with Two New FDA-Cleared Catheter Devices for Use in Complex Percutaneous Coronary Interventions (PCI)
- Teleflex to Present at the 44th Annual Raymond James Institutional Investors Conference
- Teleflex Announces Fourth Quarter 2022 Earnings Conference Call Information
